Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors [Phase 1]
Phase 1 study of palbociclib in combination with gedatolisib in patients with advanced solid tumors, including lung squamous cell carcinoma,…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: MRE for Diagnosis of Pancreatic Masses
A clinical trial is currently recruiting to evaluate magnetic resonance elastography for diagnosing pancreatic masses.
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic Tumor Treatment (PULS) [Phase 1, Phase 2]
A Phase 1/2 trial evaluating high-intensity focused ultrasound for unresectable pancreatic cancer has been suspended.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating the combination of an anti-PD-1 antibody with chemotherapy for pancreatic cancer has completed.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.
This clinical trial investigates whether transcriptome-based OncoTreat/Oncotarget profiling and patient-derived organoid testing can predict…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain
An observational study evaluating first-line systemic therapy combined with celiac plexus blockade for pain in advanced biliary tract cancer…
-
CLINICAL_TRIALS withdrawal · 2026-02-11Clinical Trial Update: Quality of Life With Nutritional Supplementation in Patients With Locally Advanced/Metastatic Pancreatic Cancer. [NA]
A clinical trial evaluating nutritional supplementation to improve quality of life in locally advanced or metastatic pancreatic cancer was w…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating a biologically optimized infusion schedule of gemcitabine and nab-paclitaxel for metastatic pancreatic can…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Pancreas Registry and High Risk Registry
Clinical trial registry update for the Pancreas Registry and High Risk Registry, focusing on pancreatic diseases and currently recruiting pa…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer. [Phase 1, Phase 2]
A Phase 1/2 trial to evaluate the safety and efficacy of XER-001 (amifostine delivered nasoduodenally) in combination with stereotactic body…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors [Phase 1]
This is a Phase 1 clinical trial evaluating the safety, tolerability, and preliminary activity of AGX101 in adults with advanced solid tumor…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer [Phase 2]
This ClinicalTrials.gov entry describes a Phase 2 trial evaluating surufatinib in combination with gemcitabine and nab-paclitaxel as peri-op…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating polymeric micellar paclitaxel for metastatic pancreatic cancer. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer [Phase 3]
A Phase 3 clinical trial update evaluating the use of standard chemotherapy before and after surgery for resectable pancreatic cancer is cur…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating NT-I7 (efineptakin alfa) in combination with pembrolizumab in adults with advanced solid tumors has completed and…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer [Phase 1]
A Phase 1 trial evaluating irreversible electroporation in combination with pembrolizumab in locally advanced pancreatic cancer has complete…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial update of P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy, being studied in advanced or metastatic solid tumors. The study is …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors [Phase 2]
This notice reports a Phase 2 clinical trial evaluating a PD-L1 inhibitor in combination with strategies targeting DNA damage and angiogenes…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study [EARLY_Phase 1]
An early Phase 1 study called CARES evaluating cancer coaching and remote education for self-empowerment in pancreatic cancer has completed.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Endocrine-exocrine Functions and Prognosis After Pancreatectomy
A recruiting clinical trial at National Taiwan University Hospital is investigating how pancreatectomy affects endocrine and exocrine pancre…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients [NA]
Clinical trial update for the STRONG program, which supports pancreatic cancer patients with remote observation and nutrition guidance; the …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer [NA]
A clinical trial (NCT06423963) is evaluating remote exercise and nutritional prehabilitation for pancreatic cancer and is currently recruiti…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
Clinical trial evaluating exosome-mediated intercellular signaling in patients with pancreatic cancer; currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
This trial aims to study obesity-related mechanisms that may drive pancreatic cancer development in minority populations. It is currently re…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating pegcetacoplan in combination with modified FOLFIRINOX for metastatic pancreatic ductal adenocarcinoma …